Pfizer completes sale of Capsugel delivery unit

Pfizer has wrapped up the sale of its Capsugel drug-delivery unit to the investment firm KKR for $2.3 billion in cash. Capsugel offers a variety of products, including liquid formulations as part of its Licaps drug delivery system. It's part of an effort by Pfizer to "make the company smaller." Pharmaceutical Business Review reports that Capsugel will keep a corporate presence with headquarters in New Jersey. Story | Release | Background

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.